2025 ahead ayondo Franchise coming soon
Happy 
xMas Holidays
xMas Holidays
xMas Holidays
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 2 December 2024 was 387.54p (cum income) Ex-dividend.
For and on behalf of the Board
Frostrow Capital LLP
Secretary
03 December 2024
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 29 November 2024 was 385.63p (cum income) Ex-dividend.
For and on behalf of the Board
Frostrow Capital LLP
Secretary
02 December 2024
Worldwide Healthcare Trust PLC
02 December 2024
Worldwide Healthcare Trust PLC
Voting Rights and Capital
In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, Worldwide Healthcare Trust PLC announces the following:
As at 30 November 2024, Worldwide Healthcare Trust PLC's capital consists of ordinary shares of 2.5p, with each ordinary share holding one voting right. The total number of ordinary shares in issue is 601,665,200. The Company has 90,405,650 ordinary shares in Treasury.
Therefore, the total number of voting rights in Worldwide Healthcare Trust PLC is 511,259,550.
The above figure (511,259,550) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in Worldwide Healthcare Trust PLC, or a change to their interest in Worldwide Healthcare Trust PLC, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
- END -
Frostrow Capital LLP
Company Secretary
Tel: 0203 008 4913
For immediate release
29 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 10 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 79,248,688.
The Company has purchased a market total of 410,000 Ordinary shares of 2.5p each in the capital of the Company today at a price of 331.32 pence per share. These shares will be held in treasury.
Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 90,405,650 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 511,259,550.
The figure of 511,259,550 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 0084913
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 28 November 2024 was 386.41p (cum income) Ex-dividend.
For and on behalf of the Board
Frostrow Capital LLP
Secretary
29 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 27 November 2024 was 386.77p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
28 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 26 November 2024 was 387.80p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
27 November 2024
For immediate release
26 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 10 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 79,248,688.
The Company has purchased a market total of 297,246 Ordinary shares of 2.5p each in the capital of the Company today at a price of 327.10 pence per share. These shares will be held in treasury.
Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 89,995,650 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 511,669,550.
The figure of 511,669,550 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 0084913
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 25 November 2024 was 381.63p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
26 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 22 November 2024 was 379.09p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
25 November 2024
For immediate release
22 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 10 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 79,248,688.
The Company has purchased a market total of 441,362 Ordinary shares of 2.5p each in the capital of the Company today at a price of 325.71 pence per share. These shares will be held in treasury.
Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 89,698,404 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 511,966,796.
The figure of 511,966,796 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 0084913
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 21 November 2024 was 374.55p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
22 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 20 November 2024 was 372.45p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
21 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 19 November 2024 was 368.39p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
20 November 2024
For immediate release
19 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 10 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 79,248,688.
The Company has purchased a market total of 149,616 Ordinary shares of 2.5p each in the capital of the Company today at a price of 323.50 pence per share. These shares will be held in treasury.
Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 89,257,042 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 512,408,158.
The figure of 512,408,158 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 0084913
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 18 November 2024 was 366.64p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
19 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 15 November 2024 was 367.87p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
18 November 2024
For immediate release
15 November 2024
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 10 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 79,248,688.
The Company has purchased a market total of 293,742 Ordinary shares of 2.5p each in the capital of the Company today at a price of 336.94 pence per share. These shares will be held in treasury.
Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 89,107,426 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 512,557,774.
The figure of 512,557,774 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 0084913
Worldwide Healthcare Trust PLC
15 November 2024
Update statement regarding the re-election of two Directors at the 2024 Annual General Meeting (AGM).
All of the resolutions proposed at the Company's AGM on 10 July 2024 were passed comfortably, although the votes in favour of the resolutions to re-elect Doug McCutcheon and Sven Borho as Directors of the Company had more than 20% of votes cast against the respective resolutions. The Board understands that some shareholders deemed Mr. McCutcheon not to be independent due to his length of service on the Board (11 years) and that Mr. Borho should not be a Director due to his role as a Managing Partner at OrbiMed Capital LLC, the Company's Portfolio Manager.
The Company is actively engaged with its shareholders on these and other matters. Mr. McCutcheon, as Chair of the Board, Mr. Borho and Dr. Bina Rawal, as Senior Independent Director on the Board, met with the Company's principal shareholders ahead of the AGM. Since then, the programme of regular meetings with shareholders has continued.
The Board shares the widely accepted view that length of service does not in itself impair a director's ability to act independently. On the contrary, the Board believes that long serving Directors' perspectives can add value to the deliberations of the Board. As stated in this year's Annual Report, Mr. McCutcheon was asked by the Board to take on the role of Board Chair from July 2022 for a period of three to five years. This was to oversee the renewal of the Board composition, to provide continuity and to ensure an orderly succession. In October of this year, the Company appointed two new additional Independent Directors, Sian Hansen and William Hemmings. With these appointments, four of the Company's six Independent Directors have joined the Board in the past 14 months. In light of the progress being made, while also enabling sufficient overlap with the newly appointed directors, Mr. McCutcheon is now expected to retire as Chair of the Company after four years at the 2026 AGM.
Mr. Borho was appointed a Director of the Company in June 2018. Mr. Borho is the only Director deemed not to be independent by the Board. The Board believes that the Company benefits from his extensive knowledge and experience in investment matters. The Board routinely takes steps to avoid any potential conflicts of interest. Each Board meeting includes a separate session for the independent Directors only, which provides the opportunity for open discussion and consideration of any areas where potential conflicts might be relevant. In addition, Mr. Borho does not sit on any of the Board's Committees and he does not receive a fee for serving as a Director.
-ENDS-
WORLDWIDE HEALTHCARE TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 14 November 2024 was 379.26p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
15 November 2024
Die hier zur Verfügung gestellten Informationen unterliegen keiner redaktionellen Bearbeitung. Die Aufbereitung erfolgt vollautomatisch und wird durch Zusatzinformationen und weiterführende Recherchemöglichkeiten angereichert. Ziel der Inhalte ist die schnelle und unkomplizierte Versorgung der Informationssuchenden mit den für sie relevanten Informationen. Durch eine Rückverlinkung auf den Informationsanbieter und -eigentümer ist sichergestellt, dass die hier aufbereiteten Daten bei Bedarf mit den Quellinformationen abgeglichen werden können. Das Newsboard zeigt keine Informationen in Echtzeit. Diese bitten wir bei Bedarf beim Börsenbetreiber abzurufen. Es besteht kein Anspruch auf Vollständigkeit. Hochverfügbarkeit kann nicht gewährleistet werden. Sollten Sie Fehler in der Funktionsweise bemerken, teilen Sie uns diese über das weiter unten befindliche Formular "Report a Bug" mit.
RAW DATA PROCESSING bedeutet, dass Rohdaten verarbeitet werden, ohne den Inhalt zu verändern. Um die Interpretation der Information im Sinne der Nutzbarkeit zu verbessern, werden die Daten ergänzt.
Hinweis: Über das Newswire-Crosslink-Panel im oberen Bereich gelangen Sie schnell und bequem zu weiteren Informationsquellen. Im Terminalview sind die Nachrichten auf Unternehmensebene gefiltert und ermöglich darüber gezielte Recherchen.
Wir bedanken uns im Namen der Trading-Community bei den Betreibern der Handelsplätze für die Bereitstellung von Informationsdiensten.
